09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3563<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
Smithkline Beecham Corporation, US A61K 31/46 (2006.01)<br />
EP 2<strong>09</strong>4269 * PYRROLIDINANILINES<br />
C07D 453/02 (2006.01)<br />
SmithKline Beecham Corporation, US C07D 401/12 (2006.01)<br />
EP 2<strong>09</strong>4683 * BICYCLIC COMPOUNDS AND USE AS<br />
C07D 401/14 (2006.01)<br />
ANTIDIABETICS<br />
C07D 211/14 (2006.01)<br />
C07D 211/24 (2006.01)<br />
C07D 211/16 (2006.01)<br />
C07D 405/14 (2006.01)<br />
C07D 413/04 (2006.01)<br />
A61K 31/4545 (2006.01)<br />
A61K 31/496 (2006.01)<br />
A61P 3/00 (2006.01)<br />
C07D 413/14 (2006.01)<br />
Smithkline Beecham Corporation, US A61K 31/045 (2006.01)<br />
EP 2<strong>09</strong>7074 * TOPICAL PHARMACEUTICAL COMPOSITION<br />
Smithkline Beecham Corporation, US C07D 213/02 (2006.01)<br />
EP 2<strong>09</strong>7378 * NOVEL SEH INHIBITORS AND THEIR USE<br />
C07D 239/34 (2006.01)<br />
C07D 239/48 (2006.01)<br />
C07D 239/50 (2006.01)<br />
C07D 251/14 (2006.01)<br />
A61K 31/44 (2006.01)<br />
A61K 31/505 (2006.01)<br />
A61K 31/506 (2006.01)<br />
A61K 31/53 (2006.01)<br />
A61P 1/16 (2006.01)<br />
A61P 9/02 (2006.01)<br />
A61P 9/04 (2006.01)<br />
A61P 9/10 (2006.01)<br />
Smithkline Beecham Corporation, US C07D 403/04 (2006.01)<br />
EP 2<strong>09</strong>7405 * ANTI-VIRAL COMPOUNDS<br />
C07D 207/<strong>09</strong> (2006.01)<br />
C07D 417/14 (2006.01)<br />
C07D 401/14 (2006.01)<br />
C07D 403/14 (2006.01)<br />
C07D 405/14 (2006.01)<br />
C07D 4<strong>09</strong>/14 (2006.01)<br />
C07D 413/04 (2006.01)<br />
SmithKline Beecham Corporation, US A01N 43/82 (2006.01)<br />
EP 2<strong>09</strong>9300 * IL-8 RECEPTOR ANTAGONISTS<br />
A61K 31/41 (2006.01)<br />
Smithkline Beecham Corporation, US C07D 401/04 (2006.01)<br />
EP 2<strong>09</strong>9778 * AMIDO ANTI-VIRAL COMPOUNDS<br />
C07D 401/14 (2006.01)<br />
C07D 417/12 (2006.01)<br />
C07D 417/14 (2006.01)<br />
C07D 419/12 (2006.01)<br />
C07D 419/14 (2006.01)<br />
A61P 31/12 (2006.01)<br />
A61P 31/14 (2006.01)<br />
SmithKline Beecham Corporation, US C07D 401/12 (2006.01)<br />
A61K 31/472 (2006.01)<br />
A61P 3/00 (2006.01)<br />
Société de Conseils de Recherches et A61K 38/27 (2006.01)<br />
d'Applications Scientifiques, S.A.S., FR A61P 17/14 (2006.01)<br />
Solidus Networks, Inc., US G06Q 30/00 (2006.01)<br />
Solvay Pharmaceuticals B.V., NL C07D 401/12 (2006.01)<br />
A61K 31/473 (2006.01)<br />
A61P 25/28 (2006.01)<br />
A61P 25/30 (2006.01)<br />
A61P 25/24 (2006.01)<br />
Solvay Pharmaceuticals B.V., NL C07K 5/06 (2006.01)<br />
C07K 5/062 (2006.01)<br />
C07K 5/065 (2006.01)<br />
C07K 5/078 (2006.01)<br />
C07F 9/30 (2006.01)<br />
A61K 38/05 (2006.01)<br />
A61P 1/00 (2006.01)<br />
A61P 9/12 (2006.01)<br />
A61P 25/16 (2006.01)<br />
A61P 25/18 (2006.01)<br />
A61P 25/22 (2006.01)<br />
A61P 25/24 (2006.01)<br />
Solyndra, Inc., US H01R 9/24 (2006.01)<br />
StatoilHydro ASA, NO E21B 21/08 (2006.01)<br />
STC.UNM, US A61K 35/14 (2006.01)<br />
EP 2<strong>09</strong>9782 *<br />
EP 2<strong>09</strong>9474 *<br />
EP 2<strong>09</strong>2474 *<br />
EP 2<strong>09</strong>1939 *<br />
EP 2<strong>09</strong>4720 *<br />
EP 2<strong>09</strong>2612 *<br />
EP 2087197 *<br />
EP 2<strong>09</strong>7087 *<br />
ISOQUINOLINECARBOXAMIDES AS INHIBITORS OF<br />
STEAROYL-COA DESATURASE (SCD)<br />
USE OF GHRELIN TO REVERSE HAIR LOSS<br />
A METHOD OF DISTRIBUTING INFORMATION VIA<br />
MOBILE DEVICES AND ENABLING ITS USE AT A<br />
POINT OF TRANSACTION<br />
COMPOUNDS WITH A COMBINATION OF<br />
CANNABINOID-CB1 ANTAGONISM AND<br />
ACETYLCHOLINESTERASE INHIBITION<br />
SELECTIVE INHIBITORS OF NEUROTENSIN<br />
DEGRADING ENZYMES<br />
APPARATUS AND METHODS FOR CONNECTING<br />
MULTIPLE PHOTOVOLTAIC MODULES<br />
ASSEMBLY FOR PRESSURE CONTROL WHEN<br />
DRILLING AND METHOD TO CONTROL PRESSURE<br />
WHEN DRILLING IN A FORMATION WITH<br />
UNPREDICTABLE HIGH FORMATION PRESSURE<br />
SUPPRESSIVE MACROPHAGES, C-REACTIVE<br />
PROTEIN AND THE TREATMENT OF SYSTEMIC<br />
LUPUS ERYTHEMATOSUS AND IMMUNE<br />
THROMBOCYTOPENIC PURPURA<br />
ISSN 1331-2030